China NMPA Drug Inspection - Seven companies including Ningxia Mingde Traditional Chinese Medicine Pieces Co., Ltd. - Smilax glabra
China NMPA drug inspection for Seven companies including Ningxia Mingde Traditional Chinese Medicine Pieces Co., Ltd. published June 29, 2018. Drug: Smilax glabra. The Ningxia Food and Drug Administration announced on June 29, 2018, the outcomes of its regional drug quality sampling
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Seven companies including Ningxia Mingde Traditional Chinese Medicine Pieces Co., Ltd. published June 29, 2018. Drug: Smilax glabra. The Ningxia Food and Drug Administration announced on June 29, 2018, the outcomes of its regional drug quality sampling
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox